首页|革兰阳性菌重症感染幼儿利奈唑胺血药浓度监测对疗效和安全性的影响

革兰阳性菌重症感染幼儿利奈唑胺血药浓度监测对疗效和安全性的影响

扫码查看
目的 分析革兰阳性菌重症感染幼儿利奈唑胺血药浓度监测对疗效和安全性的影响。方法 选取 2020 年 1 月~2023 年 12 月收治的 80 例革兰阳性菌重症感染患儿,随机分为 2 组,对照组(40 例)进行常规利奈唑胺治疗,研究组(40 例)初始进行常规利奈唑胺治疗,治疗 1 d后对其进行血药浓度监测,并根据血药浓度监测结果结合患儿综合情况调整药物剂量,给出个体化治疗方案,评估两组治疗效果、革兰阳性菌清除率并进行安全性分析。结果 治疗前,两组白细胞计数(WBC)、C反应蛋白(CRP)、丙氨酸氨基转移酶(ALT)、血尿素氮(BUN)、肌酐(Cr)水平差异无统计学意义(P>0。05);治疗后,两组ALT、BUN、Cr水平差异无统计学意义(P>0。05),治疗后研究组WBC、CRP水平低于对照组(P<0。05);治疗后对照组革兰阳性菌清除 29 例,清除率为 72。50%,研究组革兰阳性菌清除 36 例,清除率为90。00%,研究组革兰阳性菌清除率高于对照组(χ2=4。021,P=0。045);研究组总有效率高于对照组(P<0。05);研究组不良反应发生率低于对照组(P<0。05)。结论 治疗革兰阳性菌重症感染患儿时,根据利奈唑胺血药浓度监测结果进行剂量调整可提高利奈唑胺治疗效果及革兰阳性菌清除率,降低患儿炎症因子水平,减少不良反应发生。
Effect of plasma concentration monitoring of linezolid on efficacy and safety in children with severe Gram-positive bacteria infection
Objective To analyze the effect and safety of blood concentration monitoring of linezolid in children with severe Gram-positive bacteria infection.Methods A total of 80 children with severe Gram-positive bacterial infection admitted from January 2020 to December 2023 were randomly divided into two groups.The control group(40 cases)received routine linezolid treatment,and the study group(40 patients)initially received routine linezolid treatment,the blood concentration monitored was performed after 1 d of treatment,and the dose of linezolid was adjusted according to the blood concentration monitoring results combined with the comprehensive situation of the children,and the individualized treatment plan was given.The therapeutic effect and the clearance rate of Gram-positive bacteria in the two groups were evaluated,and the safety was analyzed.Results There was no significant difference in the levels of WBC,CRP,ALT,BUN and Cr between the two groups before treatment(P>0.05);and there was no significant difference in the levels of ALT,BUN and Cr between the two groups after treatment(P>0.05).After treatment,the levels of WBC and CRP in the study group were lower than those in the control group(P<0.05).After treatment,29 casas of Gram-positive bacte-ria were cleared in the control group,with a clearance rate of 72.50%,and 36 cases of Gram-positive bacteria were cleared in the study group,with a clearance rate of 90.00%.The clearance rate of Gram-positive bacteria in the study group was higher than that in the control group(χ2=4.021,P=0.045).The total effective rate of the study group was higher than that of the control group(P<0.05).The incidence of adverse reactions in the study group was lower than that in the control group(P<0.05).Conclusion When treating children with severe Gram-positive bacteria infection,dose adjustment according to the results of linezolid blood concentration monitoring can improve the therapeutic effect of linezolid and the clearance rate of Gram-positive bacteria,reduce the level of inflammatory factors,and reduce the occurrence of adverse reactions.

LinezolidGram-positive bacteriaBlood concentration monitoringTherapeutic effect evaluation

雷雪、冯雪影、白海昕

展开 >

大庆龙南医院(齐齐哈尔医学院第五附属医院)临床药学,黑龙江大庆 163453

利奈唑胺 革兰阳性菌 血药浓度 疗效评价

2023年大庆市指导性科技计划医疗项目

zdy-2023-04

2024

中国处方药
南方医药经济研究所

中国处方药

影响因子:0.649
ISSN:1671-945X
年,卷(期):2024.22(8)